VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - AUTOLOGOUS NEUTRALIZING ANTIBODY, VIRUS LOAD, AND VIRUS PHENOTYPE

被引:53
作者
HUSSON, RN
LAN, Y
KOJIMA, E
VENZON, D
MITSUYA, H
MCINTOSH, K
机构
[1] NCI, MED BRANCH, EXPTL RETROVIROL SECT, BETHESDA, MD 20892 USA
[2] NCI, BIOSTAT & DATA MANAGEMENT SECT, BETHESDA, MD 20892 USA
关键词
D O I
10.1016/S0022-3476(95)70198-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To evaluate immunologic and virologic correlates of vertical transmission of human immunodeficiency virus type 1 (HIV-1). Design: Case-control study. Patients: Women who were prospectively enrolled in a natural history study of HIV-1 infection in women and infants. Sixteen HIV-1-infected women whose infants became infected were matched by CD4(+) cell percentage and use of zidovudine during pregnancy with women whose infants did not become infected. Measurements: Maternal autologous neutralizing antibody, virus load determined by RNA-polymerase chain reaction (RNA-PCR), and virus phenotype. Results: Most women in both groups had low titers of autologous neutralizing antibody, and no difference in neutralizing titers was observed (range, <4 to 181 in both groups), The HIV-1 copy number in maternal plasma was not significantly different in the two groups but was inversely correlated with maternal CD4(+) cell percentage (p <0.005). Five women in the transmitting group and four in the nontransmitting group had syncytium-inducing (SI) phenotype virus. Two infected infants had SI phenotype virus. The SI phenotype virus was associated with a greater HIV-1 copy number in maternal plasma (p <0.05) and an increase in the mortality rate for the infants (p <0.01). Conclusions: In women matched for CD4(+) cell percentage, low titers of autologous neutralizing antibody, high virus load, and SI phenotype virus were not associated with an increased risk of transmission of HIV-1 to their infants.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 40 条
[1]  
BAL A, 1993, LACK CORRELATION MAT
[2]   A PROSPECTIVE-STUDY OF INFANTS BORN TO WOMEN SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
BLANCHE, S ;
ROUZIOUX, C ;
MOSCATO, MLG ;
VEBER, F ;
MAYAUX, MJ ;
JACOMET, C ;
TRICOIRE, J ;
DEVILLE, A ;
VIAL, M ;
FIRTION, G ;
DECREPY, A ;
DOUARD, D ;
ROBIN, M ;
COURPOTIN, C ;
CIRARUVIGNERON, N ;
LEDEIST, F ;
GRISCELLI, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (25) :1643-1648
[3]   CORRELATION OF PERINATAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH MATERNAL VIREMIA AND LYMPHOCYTE PHENOTYPES [J].
BORKOWSKY, W ;
KRASINSKI, K ;
CAO, YZ ;
HO, D ;
POLLACK, H ;
MOORE, T ;
CHEN, SH ;
ALLEN, M ;
TAO, PT .
JOURNAL OF PEDIATRICS, 1994, 125 (03) :345-351
[4]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[5]   VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IS CORRELATED WITH THE ABSENCE OF HIGH-AFFINITY AVIDITY MATERNAL ANTIBODIES TO THE GP120 PRINCIPAL NEUTRALIZING DOMAIN [J].
DEVASH, Y ;
CALVELLI, TA ;
WOOD, DG ;
REAGAN, KJ ;
RUBINSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3445-3449
[6]   RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION THROUGH BREAST-FEEDING [J].
DUNN, DT ;
NEWELL, ML ;
ADES, AE ;
PECKHAM, CS .
LANCET, 1992, 340 (8819) :585-588
[7]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[8]  
GABIANO C, 1992, PEDIATRICS, V90, P369
[9]  
GOEDERT JJ, 1989, LANCET, V2, P1351
[10]  
HALSEY NA, 1992, J ACQ IMMUN DEF SYND, V5, P153